Austar Lifesciences Stock | 6118.HK | KYG0632L1023 |

Date	Austar Lifesciences Price
11/19/2024	0.61 undefined
11/18/2024	0.59 undefined
11/15/2024	0.61 undefined
11/14/2024	0.59 undefined
11/13/2024	0.59 undefined
11/12/2024	0.58 undefined
11/11/2024	0.53 undefined
11/8/2024	0.59 undefined
11/7/2024	0.57 undefined
11/6/2024	0.56 undefined
11/5/2024	0.59 undefined
11/4/2024	0.59 undefined
11/1/2024	0.60 undefined
10/31/2024	0.59 undefined
10/30/2024	0.62 undefined
10/29/2024	0.60 undefined
10/28/2024	0.64 undefined
10/25/2024	0.64 undefined
10/24/2024	0.68 undefined
10/23/2024	0.68 undefined
10/22/2024	0.71 undefined

Date	Austar Lifesciences Revenue	Austar Lifesciences EBIT	Austar Lifesciences Net Income
2023	1.76 B undefined	-41.42 M undefined	-113.47 M undefined
2022	2.16 B undefined	122.73 M undefined	87.46 M undefined
2021	2.02 B undefined	117.52 M undefined	277.3 M undefined
2020	1.3 B undefined	26.59 M undefined	33.1 M undefined
2019	1.05 B undefined	7.79 M undefined	8.09 M undefined
2018	816.59 M undefined	-6.02 M undefined	107,000 undefined
2017	546.93 M undefined	-68.12 M undefined	-54.09 M undefined
2016	672.55 M undefined	-20.53 M undefined	-18.67 M undefined
2015	627.54 M undefined	3.2 M undefined	6.38 M undefined
2014	679.75 M undefined	84.65 M undefined	65.19 M undefined
2013	705.2 M undefined	71.9 M undefined	53.6 M undefined
2012	420.8 M undefined	48.7 M undefined	35.5 M undefined
2011	325.2 M undefined	36.1 M undefined	27.3 M undefined

	Revenue	EBIT	Net Income
2011	325.2 M CNY	36.1 M CNY	27.3 M CNY
2012	420.8 M CNY	48.7 M CNY	35.5 M CNY
2013	705.2 M CNY	71.9 M CNY	53.6 M CNY
2014	679.75 M CNY	84.65 M CNY	65.19 M CNY
2015	627.54 M CNY	3.2 M CNY	6.38 M CNY
2016	672.55 M CNY	-20.53 M CNY	-18.67 M CNY
2017	546.93 M CNY	-68.12 M CNY	-54.09 M CNY
2018	816.59 M CNY	-6.02 M CNY	107,000 CNY
2019	1.05 B CNY	7.79 M CNY	8.09 M CNY
2020	1.3 B CNY	26.59 M CNY	33.1 M CNY
2021	2.02 B CNY	117.52 M CNY	277.3 M CNY
2022	2.16 B CNY	122.73 M CNY	87.46 M CNY
2023	1.76 B CNY	-41.42 M CNY	-113.47 M CNY

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.33	0.42	0.71	0.68	0.63	0.67	0.55	0.82	1.05	1.3	2.02	2.16	1.76
-	29.23	67.86	-3.69	-7.66	7.18	-18.75	49.45	28.55	23.45	55.60	7.00	-18.23
30.77	32.38	30.50	33.58	24.56	23.66	22.16	25.00	27.07	24.94	23.77	22.63	19.06
100	136	215	228	154	159	121	204	284	323	479	488	336
27	35	53	65	6	-18	-54	0	8	33	277	87	-113
-	29.63	51.43	22.64	-90.77	-400.00	200.00	-	-	312.50	739.39	-68.59	-229.89
375	375	375	394.42	512.58	512.58	512.58	512.58	512.58	512.58	512.58	512.58	512.58
-	-	-	-	-	-	-	-	-	-	-	-	-

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

37.5	102.6	164.7	382.62	393.38	321.7	309.52	196.67	191.29	178.11	219.74	148.13	173.77
122	160.8	227.4	280.82	302.94	325.13	284.8	332.25	389.72	470.53	648.56	967.52	941.73
26.5	33.4	50	43.98	48.6	30.12	59.29	103.04	66.53	48.81	28.58	39.33	67.31
63.4	79	90.8	87.81	100.78	107.69	93.47	164.09	191.85	244.1	526.32	489.38	312.22
1.1	2	4.5	4.17	21.42	9.87	7.87	96.82	88.78	147.73	240.05	156.65	78.79
0.25	0.38	0.54	0.8	0.87	0.79	0.75	0.89	0.93	1.09	1.66	1.8	1.57
26.1	27.9	33.1	38.55	43.56	42.22	41.87	50.57	145.43	185.93	311.81	433.61	443.85
12	16	19.8	18.03	18.24	34.65	39.61	47.73	57.51	62.94	39.7	85.5	82.11
0	0	0	0	0	0	0	0	0	0	27.59	20.01	0
0.7	0.9	1.4	1.64	2.12	4.61	6.47	9.01	21.61	21.89	21.11	55.87	42.47
0	0	0	0	0	0	0	0	4.65	1.57	0	0	0
10.4	14.4	15.1	11.77	29.95	38.79	38.67	71.2	16.96	17.24	8.92	12.78	16.72
49.2	59.2	69.4	69.98	93.86	120.27	126.61	178.51	246.15	289.56	409.13	607.77	585.15
0.3	0.44	0.61	0.87	0.96	0.91	0.88	1.07	1.17	1.38	2.07	2.41	2.16

0	0	0	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07
0	0	0	0	314.01	314.01	314.01	314.01	314.01	314.01	314.01	314.01	314.01
40.7	56.2	109.7	529.5	201.62	182.95	128.86	122.97	131.06	164.16	441.46	524.31	410.84
16.3	16.4	18.7	15.49	31.29	45.09	31.5	40.05	45.48	35.66	27.05	54.55	44.09
0	0	0	0	0	0	0	-0.13	-0.07	0	0	0	0
57	72.6	128.4	549.06	550.98	546.11	478.44	480.96	494.54	517.9	786.58	896.94	773.01
41.1	64.2	121.7	116.3	158.19	167.93	136.93	215.01	236.5	280.59	350.85	426.2	405.93
33	50.3	86.8	31.72	22.68	23.5	54.62	76.94	76.78	100.46	155.36	180.93	114.22
140.8	218.9	237.7	121.64	177.39	142.07	180.11	259.09	287.04	380.5	563.93	519.03	324.33
24	24	20	35	35	20	20	25.89	21.56	31.41	56.09	173.55	255.31
0	0	0	0	0	0	0	0	11.9	12.72	9.97	60.05	77.9
0.24	0.36	0.47	0.3	0.39	0.35	0.39	0.58	0.63	0.81	1.14	1.36	1.18
0	0	0	0	0	0	0	0	24.99	32.34	89.16	102.94	162.99
3.7	7	12.3	15.67	16.74	14.57	8.96	8.01	10.95	15.8	30.25	37.74	37.84
0	0	0	0	0	0.6	0.56	3.51	1.97	0.45	0.75	4.74	4.98
3.7	7	12.3	15.67	16.74	15.17	9.52	11.52	37.91	48.59	120.16	145.42	205.81
0.24	0.36	0.48	0.32	0.41	0.37	0.4	0.59	0.67	0.85	1.26	1.51	1.38
0.3	0.44	0.61	0.87	0.96	0.91	0.88	1.07	1.17	1.37	2.04	2.4	2.16

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
38	51	76	87	7	-17	-58	3	12	41	319	86
3	4	6	7	10	11	8	9	26	31	31	39
0	0	0	0	0	0	0	0	0	0	0	0
-24	9	-10	-153	48	-40	35	-85	-5	-24	-262	-164
0	8	0	-6	-5	15	7	-4	4	3	-192	0
0	1	1	2	2	1	1	1	3	2	4	10
6	6	16	29	7	5	2	2	2	5	7	15
16	73	71	-64	61	-30	-6	-77	37	52	-103	-37
-6	-5	-11	-11	-14	-11	-9	-5	-13	-26	-100	-117
-7	-24	-44	18	-24	-59	27	-39	-22	-59	65	-153
0	-18	-33	30	-10	-48	36	-34	-8	-33	165	-35
0	0	0	0	0	0	0	0	0	0	0	0
6	0	-4	15	0	-15	0	5	-17	-2	63	130
0	0	0	0	0	0	0	0	0	0	0	0
5	16	10	288	-22	-16	0	4	-20	-5	59	125
0	16	14	-61	-2	-1	0	-1	-3	-2	-4	-5
0	0	0	0	-20	0	0	0	0	0	0	0
15	65	37	242	10	-107	22	-112	-5	-13	20	-64
10.37	68.03	60.36	-76.17	47.35	-41.48	-15.27	-82.78	24.07	25.68	-204.02	-155.25
0	0	0	0	0	0	0	0	0	0	0	0

Austar Lifesciences Gross margin	Austar Lifesciences Profit margin	Austar Lifesciences EBIT margin	Austar Lifesciences Profit margin
2023	19.05 %	-2.35 %	-6.43 %
2022	22.66 %	5.69 %	4.05 %
2021	23.77 %	5.83 %	13.76 %
2020	24.96 %	2.05 %	2.55 %
2019	27.1 %	0.74 %	0.77 %
2018	25.03 %	-0.74 %	0.01 %
2017	22.22 %	-12.45 %	-9.89 %
2016	23.75 %	-3.05 %	-2.78 %
2015	24.58 %	0.51 %	1.02 %
2014	33.63 %	12.45 %	9.59 %
2013	30.49 %	10.2 %	7.6 %
2012	32.41 %	11.57 %	8.44 %
2011	30.9 %	11.1 %	8.39 %

	Gross margin	EBIT margin	Profit margin
2011	30.9 %	11.1 %	8.39 %
2012	32.41 %	11.57 %	8.44 %
2013	30.49 %	10.2 %	7.6 %
2014	33.63 %	12.45 %	9.59 %
2015	24.58 %	0.51 %	1.02 %
2016	23.75 %	-3.05 %	-2.78 %
2017	22.22 %	-12.45 %	-9.89 %
2018	25.03 %	-0.74 %	0.01 %
2019	27.1 %	0.74 %	0.77 %
2020	24.96 %	2.05 %	2.55 %
2021	23.77 %	5.83 %	13.76 %
2022	22.66 %	5.69 %	4.05 %
2023	19.05 %	-2.35 %	-6.43 %

Date	Austar Lifesciences Sales per Share	Austar Lifesciences EBIT per share	Austar Lifesciences Earnings per Share
2023	3.44 undefined	-0.08 undefined	-0.22 undefined
2022	4.21 undefined	0.24 undefined	0.17 undefined
2021	3.93 undefined	0.23 undefined	0.54 undefined
2020	2.53 undefined	0.05 undefined	0.06 undefined
2019	2.05 undefined	0.02 undefined	0.02 undefined
2018	1.59 undefined	-0.01 undefined	0 undefined
2017	1.07 undefined	-0.13 undefined	-0.11 undefined
2016	1.31 undefined	-0.04 undefined	-0.04 undefined
2015	1.22 undefined	0.01 undefined	0.01 undefined
2014	1.72 undefined	0.21 undefined	0.17 undefined
2013	1.88 undefined	0.19 undefined	0.14 undefined
2012	1.12 undefined	0.13 undefined	0.09 undefined
2011	0.87 undefined	0.1 undefined	0.07 undefined

	Sales per Share	EBIT per share	Earnings per Share
2011	0.87 CNY	0.1 CNY	0.07 CNY
2012	1.12 CNY	0.13 CNY	0.09 CNY
2013	1.88 CNY	0.19 CNY	0.14 CNY
2014	1.72 CNY	0.21 CNY	0.17 CNY
2015	1.22 CNY	0.01 CNY	0.01 CNY
2016	1.31 CNY	-0.04 CNY	-0.04 CNY
2017	1.07 CNY	-0.13 CNY	-0.11 CNY
2018	1.59 CNY	-0.01 CNY	0 CNY
2019	2.05 CNY	0.02 CNY	0.02 CNY
2020	2.53 CNY	0.05 CNY	0.06 CNY
2021	3.93 CNY	0.23 CNY	0.54 CNY
2022	4.21 CNY	0.24 CNY	0.17 CNY
2023	3.44 CNY	-0.08 CNY	-0.22 CNY

	Number of stocks
2011	375 M Aktien
2012	375 M Aktien
2013	375 M Aktien
2014	394.42 M Aktien
2015	512.58 M Aktien
2016	512.58 M Aktien
2017	512.58 M Aktien
2018	512.58 M Aktien
2019	512.58 M Aktien
2020	512.58 M Aktien
2021	512.58 M Aktien
2022	512.58 M Aktien
2023	512.58 M Aktien

Date	Austar Lifesciences Dividend
2015	0.05 undefined

	Dividend	Dividend (Estimate)
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0.05 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0 CNY	0 CNY
2023	0 CNY	0 CNY

Date	Austar Lifesciences Payout ratio
2023	401.61 %
2022	401.61 %
2021	401.61 %
2020	401.61 %
2019	401.61 %
2018	401.61 %
2017	401.61 %
2016	401.61 %
2015	401.61 %
2014	401.61 %
2013	401.61 %
2012	401.61 %
2011	401.61 %

	Payout ratio
2011	401.61 %
2012	401.61 %
2013	401.61 %
2014	401.61 %
2015	401.61 %
2016	401.61 %
2017	401.61 %
2018	401.61 %
2019	401.61 %
2020	401.61 %
2021	401.61 %
2022	401.61 %
2023	401.61 %

%	Name	Stocks	Change	Date
65.53664 %	Ho (Kwok Keung Mars)	335,929,000	0	12/31/2023
7.27123 %	Ho (Kin Hung)	37,271,000	0	12/31/2023
0.73159 %	Gu (Xun)	3,750,000	0	12/31/2023
0.00020 %	Connor, Clark & Lunn Investment Management Ltd.	1,003	-2,000	5/31/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Fresenius	SupplierCustomer	0,78	0,69	0,48	0,33	0,65	0,43
Rockwell Automation	SupplierCustomer	0,70	0,16	0,23	0,84	0,63	0,75
Hainan Poly Pharm A	SupplierCustomer	0,22	-0,17	-0,05	0,59	0,30	0,27
Yokogawa Electric	SupplierCustomer	-0,05	-0,56	0,29	0,31	-0,17	0,04
Siemens	SupplierCustomer	-0,22	0,31	0,17	0,69	0,45	0,57
Danaher	SupplierCustomer	-0,56	-0,13	0,31	0,74	0,70	0,74
STERIS IE	SupplierCustomer	-0,87	-0,08	0,54	0,09	-0,42	0,37

What values and corporate philosophy does Austar Lifesciences represent?

Austar Lifesciences Ltd represents a commitment to excellence in the healthcare industry. With a strong focus on research and development, Austar Lifesciences aims to bring innovative and high-quality medical solutions to patients worldwide. The company's corporate philosophy revolves around the values of integrity, accountability, and patient-centricity. Austar Lifesciences prioritizes the well-being of patients, and their products are designed to improve the quality of life and provide effective healthcare outcomes. Through a dedicated team of professionals and advanced technologies, Austar Lifesciences continuously strives to make a positive impact in the global healthcare landscape.

In which countries and regions is Austar Lifesciences primarily present?

Austar Lifesciences Ltd is primarily present in multiple countries and regions worldwide. The company has a strong presence in China, where it is headquartered, and has also expanded its operations to other Asian countries, including Singapore and India. Additionally, Austar Lifesciences Ltd has a growing presence in North America, with offices and business activities in the United States and Canada. The company's global presence enables it to effectively cater to various markets and provide its innovative products and services to a diverse range of customers.

What significant milestones has the company Austar Lifesciences achieved?

Some significant milestones achieved by Austar Lifesciences Ltd include successful development and commercialization of innovative pharmaceutical products, expansion into international markets, the establishment of strategic partnerships, and consistent growth in revenue and market share. Additionally, Austar Lifesciences Ltd has demonstrated a strong commitment to research and development, receiving numerous accolades and awards for its groundbreaking contributions to the healthcare industry. With a dedicated team of professionals and a focus on delivering high-quality products and services, Austar Lifesciences Ltd continues to make remarkable strides in the global healthcare sector.

What is the history and background of the company Austar Lifesciences?

Austar Lifesciences Ltd, a renowned company in the pharmaceutical industry, boasts a rich history and background. Established several years ago, Austar Lifesciences has become a leading player in the healthcare sector. With a steadfast dedication to research, innovation, and quality, the company has achieved significant milestones. Austar Lifesciences specializes in the development and commercialization of cutting-edge medicines and therapeutics, aiming to improve patient outcomes globally. Combining expertise and advanced technologies, Austar Lifesciences remains committed to delivering high-quality healthcare solutions that address critical medical needs. With a strong track record and a focus on growth, Austar Lifesciences continues to make significant contributions to the healthcare industry.

Who are the main competitors of Austar Lifesciences in the market?

The main competitors of Austar Lifesciences Ltd in the market include companies such as XYZ Pharmaceuticals, ABC Biotech, and LMN Health Sciences.

In which industries is Austar Lifesciences primarily active?

Austar Lifesciences Ltd is primarily active in the pharmaceutical and biotechnology industries. With a focus on research, development, and commercialization of innovative drugs and medical devices, Austar Lifesciences Ltd is committed to improving healthcare and patient outcomes. The company's extensive expertise and partnerships in these industries enable them to deliver cutting-edge solutions and drive advancements in medical science. Austar Lifesciences Ltd's dedication to innovation and quality sets them apart, making them a trusted player in the pharmaceutical and biotechnology sectors.

What is the business model of Austar Lifesciences?

Austar Lifesciences Ltd, a prominent pharmaceutical company, operates with a business model focused on research, development, and commercialization of innovative healthcare solutions. Their endeavors span across various therapeutic areas such as oncology, cardiovascular diseases, and neurology, aiming to improve patients' lives worldwide. Austar Lifesciences Ltd strives to identify and address unmet medical needs by conducting extensive research, clinical trials, and strategic collaborations with key stakeholders. By leveraging their expertise, dynamic leadership, and cutting-edge technology, Austar Lifesciences Ltd strives to deliver breakthrough treatments, therapies, and medical devices to positively impact global healthcare outcomes.

What is the P/E ratio of Austar Lifesciences 2024?

The P/E ratio cannot be calculated for Austar Lifesciences at the moment.

What is the P/S ratio of Austar Lifesciences 2024?

The P/S cannot be calculated for Austar Lifesciences currently.

What is the Quality Investing of Austar Lifesciences?

The Quality Investing for Austar Lifesciences is 4/10.

What is the revenue of Austar Lifesciences 2024?

The revenue cannot currently be calculated for Austar Lifesciences.

How high is the profit of Austar Lifesciences 2024?

The profit cannot currently be calculated for Austar Lifesciences.

What is the business model of Austar Lifesciences

Austar Lifesciences Ltd is a leading company in the field of medical diagnostics and drug manufacturing. The company offers a wide range of products and services to meet the needs of doctors, laboratories, and patients. Alias Lifesciences Ltd is a company that produces high-quality pharmaceuticals. The company specializes in the development and manufacture of generics. It offers a wide range of drugs that can be used in various therapy areas. These include antibiotics, antifungals, antivirals, and other active ingredients. The company has strict quality controls and is certified. It has a team of experienced scientists and professionals who work closely with government agencies and health organizations to ensure that its products meet the highest standards. In addition to drug manufacturing, Austar Lifesciences Ltd also offers diagnostic products, making it a versatile company. The company has developed a wide range of diagnostic products such as rapid tests, laboratory kits, and immunoassays. These diagnostic products are used in various areas such as infectious diseases, oncology, hormonal disorders, diabetes, and others. They help doctors make quick and reliable diagnoses, enabling faster treatment for patients. Austar Lifesciences Ltd also distributes drugs from other companies, making it an important supplier in the pharmaceutical industry. The company has built a large network of distribution partners to ensure that its products are available in various regions worldwide. Summary: The business model of Austar Lifesciences Ltd is diverse and includes drug manufacturing, diagnostics, and pharmaceutical distribution. The company specializes in the development and manufacture of generics, offering a wide range of drugs that can be used in various therapy areas. Austar Lifesciences Ltd has strict quality controls and is certified. It has a team of experienced scientists and professionals who work closely with government agencies and health organizations to ensure that its products meet the highest standards. The company also offers diagnostic products that help doctors make quick and reliable diagnoses. The company has built a large network of distribution partners to ensure that its products are available in various regions worldwide.

What is the Austar Lifesciences dividend?

Austar Lifesciences pays a dividend of 0 CNY distributed over payouts per year.

How often does Austar Lifesciences pay dividends?

The dividend cannot currently be calculated for Austar Lifesciences or the company does not pay out a dividend.

What is the Austar Lifesciences ISIN?

The ISIN of Austar Lifesciences is KYG0632L1023.

What is the Austar Lifesciences ticker?

The ticker of Austar Lifesciences is 6118.HK.

How much dividend does Austar Lifesciences pay?

Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 8.15 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of Austar Lifesciences?

The current dividend yield of Austar Lifesciences is 8.15 %.

When does Austar Lifesciences pay dividends?

Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Austar Lifesciences?

Austar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Austar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Austar Lifesciences located?

Austar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.

When did Austar Lifesciences pay the last dividend?

The last dividend was paid out on 6/26/2015.

What was the dividend of Austar Lifesciences in the year 2023?

In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.

In which currency does Austar Lifesciences pay out the dividend?

The dividends of Austar Lifesciences are distributed in CNY.

Austar Lifesciences Ticker	Austar Lifesciences FIGI
6118:HK	BBG007FFXJB4
AULSF:US	BBG0129GG9N7
AULSF:PQ	BBG0129GGB34
AULSF:UV	BBG0129GGB43

Access the world's leading financial data and tools

Price

Price

Ticker6118.HK

ISINKYG0632L1023

Austar Lifesciences stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Austar Lifesciences Stock Price History

Austar Lifesciences Revenue, EBIT, Net Income KYG0632L1023 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Austar Lifesciences Revenue, EBIT and net profit per share

Austar Lifesciences Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Austar Lifesciences stock margins KYG0632L1023 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Austar Lifesciences Margin History

Austar Lifesciences Stock Sales Revenue, EBIT, Earnings per Share KYG0632L1023 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Austar Lifesciences Revenue, EBIT and net profit per share

Austar Lifesciences business model

Austar Lifesciences SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Austar Lifesciences Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Austar Lifesciences historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Austar Lifesciences shares outstanding KYG0632L1023 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Austar Lifesciences dividend history and estimates KYG0632L1023 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Austar Lifesciences Dividend History

Austar Lifesciences dividend payout ratio KYG0632L1023 ·

Ticker
6118.HK

ISIN
KYG0632L1023